Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients

References

• Ambrogio MW, Frasconi M, Yilmaz MD, Chen X. (2013). New methods for improved characterization of silica nanoparticle-based drug delivery systems. Langmuir 29:15386–93.
   PubMed Web of Science ®Google Scholar
• Balaji S, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Synthesis and structure of arene Ru(II) N∧O-chelating complexes: in vitro cytotoxicity and cancer cell death mechanism. Organometallics 39:1366–75.
   Web of Science ®Google Scholar
• Bang Y-J, Xu R-H, Chin K, et al. (2017). Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol 18:1637–51.
   PubMed Web of Science ®Google Scholar
• Bernards N, Ventura M, Fricke IB, et al. (2018). Liposomal irinotecan achieves significant survival and tumor burden control in a triple negative breast cancer model of spontaneous metastasis. Mol Pharm 15:4132–8.
   PubMed Web of Science ®Google Scholar
• Broza YY, Vishinkin R, Barash O, et al. (2018). Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation. Chem Soc Rev 47:4781–859.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wan L, Yuan Y, et al. (2020). pH/GSH-dual-sensitive hollow mesoporous silica nanoparticle-based drug delivery system for targeted cancer therapy. ACS Biomater Sci Eng 6:3375–87.
   PubMed Web of Science ®Google Scholar
• Chourasiya V, Bohrey S, Pandey A. (2016). Formulation, optimization, characterization and in-vitro drug release kinetics of atenolol loaded PLGA nanoparticles using 33 factorial design for oral delivery. Mater Discover 5:1–13.
   Google Scholar
• Deepika MS, Thangam R, Sundarraj S, et al. (2020). Co-delivery of diverse therapeutic compounds using PEG–PLGA nanoparticle cargo against drug-resistant bacteria: an improved anti-biofilm strategy. ACS Appl Bio Mater 3:385–99.
   PubMedGoogle Scholar
• Ding S, Khan AI, Cai X, et al. (2020). Overcoming blood–brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today 37:112–25.
   Web of Science ®Google Scholar
• Evans BC, Nelson CE, Yu SS, et al. (2013). Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Vis Exp e50166.
   Google Scholar
• Florek J, Caillard R, Kleitz F. (2017). Evaluation of mesoporous silica nanoparticles for oral drug delivery – current status and perspective of MSNs drug carriers. Nanoscale 9:15252–77.
   PubMed Web of Science ®Google Scholar
• Ge Z, Liu S. (2013). Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem Soc Rev 42:7289–325.
   PubMed Web of Science ®Google Scholar
• Guo X-S, Zhang Z-K, Zhang T-Y, et al. (2019). Interfacial self-assembly of amphiphilic conjugated block copolymer into 2D nanotapes. Soft Matter 15:8790–9.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Dunderdale GJ, England MW, Hozumi A. (2017). Oil/water separation techniques: a review of recent progresses and future directions. J Mater Chem A 5:16025–58.
   Web of Science ®Google Scholar
• Hsu M-Y, Huang Y-T, Weng C-J, et al. (2020). Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection. Colloids Surf B Biointerfaces 190:110937.
   PubMed Web of Science ®Google Scholar
• Jayanathan M, Erwin RP, Molacek N, et al. (2020). MAGIC versus MacDonald treatment regimens for gastric cancer: trends and predictors of multimodal therapy for gastric cancer using the National Cancer Database. Am J Surg 219:129–35.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Pflug K, Usama SM, et al. (2019). Cyanine–gemcitabine conjugates as targeted theranostic agents for glioblastoma tumor cells. J Med Chem 62:9236–45.
   PubMed Web of Science ®Google Scholar
• Kasibhatla S, Amarante-Mendes GP, Finucane D, et al. (2006). Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. CSH Protoc 2006:799–803.
   Google Scholar
• Konstantinopoulos PA, Cheng S-C, Wahner Hendrickson AE, et al. (2020). Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 21:957–68.
   PubMed Web of Science ®Google Scholar
• Kumar A, Chen F, Mozhi A, et al. (2013). Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale 5:8307–25.
   PubMed Web of Science ®Google Scholar
• Kumari R, Sunil D, Ningthoujam RS. (2020). Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review. J Control Release 319:135–56.
   PubMed Web of Science ®Google Scholar
• Li H, Li S, Li Z, et al. (2017). Polysulfone/SiO2 hybrid shell microcapsules synthesized by the combination of pickering emulsification and the solvent evaporation technique and their application in self-lubricating composites. Langmuir 33:14149–55.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang D, Zhang J, et al. (2019). A three-in-one immunotherapy nanoweapon via cascade-amplifying cancer-immunity cycle against tumor metastasis, relapse, and postsurgical regrowth. Nano Lett 19:6647–57.
   PubMed Web of Science ®Google Scholar
• Li X, Lu X, Xu H, et al. (2012). Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on “oxidation therapy". Mol Pharm 9:222–9.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Xu C, et al. (2015). Synthesis and biological evaluation of nitric oxide-releasing hybrids from gemcitabine and phenylsulfonyl furoxans as anti-tumor agents. Med Chem Commun 6:1130–6.
   Web of Science ®Google Scholar
• Liang J-R, Yang H. (2020). Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS. Biomed Pharmacother 125:109585.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhao X, Hu T, et al. (2019). Mussel-inspired, antibacterial, conductive, antioxidant, injectable composite hydrogel wound dressing to promote the regeneration of infected skin. J Colloid Interface Sci 556:514–28.
   PubMed Web of Science ®Google Scholar
• Lin Y-H, Chen Z-R, Lai C-H, et al. (2015). Active targeted nanoparticles for oral administration of gastric cancer therapy. Biomacromolecules 16:3021–32.
   PubMed Web of Science ®Google Scholar
• Liu K, Liu P, Liu R, Wu X. (2015). Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med Sci Monit Basic Res 21:15–20.
   PubMed Web of Science ®Google Scholar
• Martínez-López AL, Pangua C, Reboredo C, et al. (2020). Protein-based nanoparticles for drug delivery purposes. Int J Pharm 581:119289.
   PubMed Web of Science ®Google Scholar
• Meng H, Zhao Y, Dong J, et al. (2013). Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. ACS Nano 7:10048–65.
   PubMed Web of Science ®Google Scholar
• Mirza Z, Karim S. (2019). Nanoparticles-based drug delivery and gene therapy for breast cancer: recent advancements and future challenges. Semin Cancer Biol.
   Google Scholar
• Mohamed Subarkhan MK, Ramesh R, Liu Y. (2016). Synthesis and molecular structure of arene ruthenium(II) benzhydrazone complexes: impact of substitution at the chelating ligand and arene moiety on antiproliferative activity. New J Chem 40:9813–23.
   Web of Science ®Google Scholar
• Mohamed Subarkhan MK, Ren L, Xie B, et al. (2019). Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo. Eur J Med Chem 179:246–56.
   PubMed Web of Science ®Google Scholar
• Mohan N, Mohamed Subarkhan MK, Ramesh R. (2018). Synthesis, antiproliferative activity and apoptosis-promoting effects of arene ruthenium(II) complexes with N, O chelating ligands. J Organomet Chem 859:124–31.
   Web of Science ®Google Scholar
• Mohamed Subarkhan M, Sundar S, Rengan R. (2018). Synthesis and structure of new binuclear ruthenium(II) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction. Inorg Chem Front 5:585–96.
   Web of Science ®Google Scholar
• Namiki Y, Fuchigami T, Tada N, et al. (2011). Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Acc Chem Res 44:1080–93.
   PubMed Web of Science ®Google Scholar
• Rehana D, Mahendiran D, Kumar RS, Rahiman AK. (2017). Evaluation of antioxidant and anticancer activity of copper oxide nanoparticles synthesized using medicinally important plant extracts. Biomed Pharmacother 89:1067–77.
   PubMed Web of Science ®Google Scholar
• Rong L, Li Z, Leng X, et al. (2020). Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway. Biomed Pharmacother 122:109726.
   PubMed Web of Science ®Google Scholar
• Safari H, Adili R, Holinstat M, Eniola-Adefeso O. (2018). Modified two-step emulsion solvent evaporation technique for fabricating biodegradable rod-shaped particles in the submicron size range. J Colloid Interface Sci 518:174–83.
   PubMed Web of Science ®Google Scholar
• Sasada A, Takagi M, Tabata S, et al. (2015). A patient with stage IV gastric cancer who acquired complete remission after undergoing multi-peptide dendritic cell immunotherapy in combination with standard therapies. Personal Med Univ 4:70–2.
   Google Scholar
• Sathiya Kamatchi T, Mohamed Subarkhan MK, Ramesh R, et al. (2020). Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(II) carbazole-based hydrazone complexes. Dalton Trans 49:11385–95.
   PubMed Web of Science ®Google Scholar
• Shen B, Ma Y, Yu S, Ji C. (2016). Smart multifunctional magnetic nanoparticle-based drug delivery system for cancer thermo-chemotherapy and intracellular imaging. ACS Appl Mater Interfaces 8:24502–8.
   PubMed Web of Science ®Google Scholar
• Sobot D, Mura S, Couvreur P. (2016). How can nanomedicines overcome cellular-based anticancer drug resistance? J Mater Chem B 4:5078–100.
   PubMed Web of Science ®Google Scholar
• Stein S, Auel T, Kempin W, et al. (2018). Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly(d,l-lactide-co-glycolide) or polycaprolactone. Eur J Pharm Biopharm 127:270–8.
   PubMed Web of Science ®Google Scholar
• Subarkhan MKM, Ramesh R. (2016). Ruthenium(II) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity. Inorg Chem Front 3:1245–55.
   Web of Science ®Google Scholar
• Tambe P, Kumar P, Paknikar KM, Gajbhiye V. (2018). Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells. Int J Nanomedicine 13:7669–80.
   PubMed Web of Science ®Google Scholar
• Thompson BR, Shi J, Zhu H-J, Smith DE. (2020). Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice. Biochem Pharmacol 180:114127.
   PubMed Web of Science ®Google Scholar
• Tramer F, Da Ros T, Passamonti S. (2012). Screening of fullerene toxicity by hemolysis assay. Methods Mol Biol 926:203–17.
   PubMedGoogle Scholar
• Wang X-P, Wang Q-X, Lin H-P, Chang N. (2017). Anti-tumor bioactivities of curcumin on mice loaded with gastric carcinoma. Food Funct 8:3319–26.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang F, Shen Y, et al. (2018). Tumor-specific disintegratable nanohybrids containing ultrasmall inorganic nanoparticles: from design and improved properties to cancer applications. Mater Horiz 5:184–205.
   Web of Science ®Google Scholar
• Xin J, Zhang X, Liang J, et al. (2013). In vivo gastric cancer targeting and imaging using novel symmetric cyanine dye-conjugated GX1 peptide probes. Bioconjug Chem 24:1134–43.
   PubMed Web of Science ®Google Scholar
• Yan L, Liu G, Cao H, et al. (2019). Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation. Biochem Biophys Res Commun 519:172–8.
   PubMed Web of Science ®Google Scholar
• Yang Y, Toy W, Choong LY, et al. (2012). Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging. J Proteome Res 11:5736–47.
   PubMed Web of Science ®Google Scholar
• Yixuan Y, Kiat LS, Yee CL, et al. (2010). Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res 9:4767–78.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang J, Li Q, et al. (2019). Cold to hot: rational design of a minimalist multifunctional photo-immunotherapy nanoplatform toward boosting immunotherapy capability. ACS Appl Mater Interfaces 11:32633–46.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Q, Liu R, et al. (2018). A versatile prodrug strategy to in situ encapsulate drugs in MOF nanocarriers: a case of cytarabine-IR820 prodrug encapsulated ZIF-8 toward chemo-photothermal therapy. Adv Funct Mater 28:1802830.
   Web of Science ®Google Scholar
• Zhang H, Zhang J, Li Q, et al. (2020). Site-specific MOF-based immunotherapeutic nanoplatforms via synergistic tumor cells-targeted treatment and dendritic cells-targeted immunomodulation. Biomaterials 245:119983.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhao Y, Di Y, et al. (2019). DNA aptamers from whole-serum SELEX as new diagnostic agents against gastric cancer. RSC Adv 9:950–7.
   PubMed Web of Science ®Google Scholar
• Zhou J, Pishko MV, Lutkenhaus JL. (2014). Thermoresponsive layer-by-layer assemblies for nanoparticle-based drug delivery. Langmuir 30:5903–10.
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhu Y, Chen X, et al. (2020). Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel. Mater Sci Eng C 114:111006.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Gong Y-B, Xu H-M. (2020). Neoadjuvant therapy strategies for advanced gastric cancer: current innovations and future challenges. Chron Dis Transl Med 6:147–57.
   PubMedGoogle Scholar